Monitor for imminent pricing supplements or prospectus filings that will reveal offering size, price, and use of proceeds. Given the small market cap, even a modest equity raise could lead to sharp downside pressure on the stock. Consider hedging or reducing exposure ahead of any announced offering.
SNGX drugs
SNGX drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 6 $1.14entry
- T+1 · 7mo ago 0.00%α −0.06% · $1.14
- T+5 · 7mo ago +0.88%α −3.26% · $1.15
- T+20 · 7mo ago −69.30%α −78.28% · $0.3500
- T+60 · 5mo ago −65.18%α −78.64% · $0.3970
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Soligenix, Inc. (SNGX) has had four separate shelf registration statements (Forms S-3) become effective, allowing the company to raise capital through future offerings of securities. The filings do not disclose specific offering sizes or terms, but signal potential dilution risk given the company's small $12M market cap.
Key Facts
- Four EFFECT filings were submitted on April 3, 2026, with effectiveness dated April 2, 2026.
- Each relates to a previously filed Form S-3 shelf registration: 333-290413, 333-280993, 333-276511, and 333-271049.
- No specific offering size, price, or security type is disclosed in the EFFECT notices.
- Company has a market capitalization of $12M, making any future equity issuance highly dilutive.
- Multiple concurrent effective shelf registrations suggest an aggressive capital-raising posture.
Financial Impact
Potential for significant dilution depending on future offering size and pricing.
Risk Factors
- Significant share dilution from upcoming equity offerings
- Downward pressure on stock price due to supply overhang
- Lack of transparency on use of proceeds or offering terms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (SNGX), Batch item 1 | 9999999995-26-001064 |
| Document: 9999999995-26-001064-index.html | 9999999995-26-001059 |
| Document: 9999999995-26-001064.txt | 9999999995-26-001056 |
| EFFECT Filing (SNGX), Batch item 4 | 9999999995-26-001059 |
| Document: 9999999995-26-001059-index.html | 9999999995-26-001064 |
| Document: 9999999995-26-001059.txt | 9999999995-26-001064 |
| EFFECT Filing (SNGX), Batch item 7 | 9999999995-26-001056 |
| Document: 9999999995-26-001056-index.html | 9999999995-26-001064 |
| Document: 9999999995-26-001056.txt | 9999999995-26-001064 |
| EFFECT Filing (SNGX), Batch item 10 | 9999999995-26-001058 |
| Document: 9999999995-26-001058-index.html | 9999999995-26-001064 |
| Document: 9999999995-26-001058.txt | 9999999995-26-001064 |
Track record
7 reports on SNGX
4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +56.04% at T+20 after the May 28, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $0.3350 Now $0.2900 −13.43% settles Feb 4
- Nov 2, 202614d ago SC 13G/A Neutral 2/10 Entry $0.3612 Now $0.2900 −19.71% settles Jan 29
- Jun 26, 202620w ago 8-K Bearish 6/10 Entry $0.4000 to $0.3850 Now $0.2900 +27.50% ▲ +3.75% +8.14% vs SPY
- Jun 26, 202620w ago 424B5 Bearish 7/10 Entry $0.4000 to $0.3850 Now $0.2900 +27.50% ▲ +3.75% +8.14% vs SPY
- May 28, 202624w ago 8-K Bearish 5/10 Entry $0.9100 to $0.4047 Now $0.2900 +68.13% ▲ +55.53% +56.71% vs SPY
- May 28, 202624w ago 424B5 Bearish 6/10 Entry $0.9100 to $0.4047 Now $0.2900 +68.13% ▲ +55.53% +56.71% vs SPY
- Apr 3, 202632w ago EFFECT Bearish 6/10 Viewing Entry $1.14 to $0.3970 Now $0.2900 +74.56% ▲ +65.18% +78.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers